Search

Carlsberg A-S (Class B)

Suletud

887.8 0.59

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

882.6

Max

898.6

Põhinäitajad

By Trading Economics

Sissetulek

-968M

2.6B

Müük

-2.6B

43B

Aktsiakasum

5.81

Kasumimarginaal

5.999

EBITDA

-2.2B

7.1B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+17.86% upside

Carlsberg A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. märts 2026, 21:14 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15. märts 2026, 21:14 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16. märts 2026, 00:00 UTC

Uudisväärsed sündmused

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15. märts 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15. märts 2026, 23:44 UTC

Market Talk
Uudisväärsed sündmused

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15. märts 2026, 23:35 UTC

Market Talk
Uudisväärsed sündmused

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15. märts 2026, 23:00 UTC

Omandamised, ülevõtmised, äriostud

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15. märts 2026, 22:37 UTC

Market Talk

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15. märts 2026, 22:18 UTC

Market Talk

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15. märts 2026, 22:14 UTC

Tulu

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15. märts 2026, 22:14 UTC

Tulu

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15. märts 2026, 22:14 UTC

Tulu

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15. märts 2026, 22:14 UTC

Tulu

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15. märts 2026, 22:14 UTC

Tulu

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15. märts 2026, 22:00 UTC

Uudisväärsed sündmused

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15. märts 2026, 22:00 UTC

Uudisväärsed sündmused

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15. märts 2026, 03:00 UTC

Uudisväärsed sündmused

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14. märts 2026, 15:00 UTC

Uudisväärsed sündmused

Iran War Delivers Windfall to America's Oil Country -- WSJ

14. märts 2026, 02:03 UTC

Tulu

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14. märts 2026, 01:32 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14. märts 2026, 00:29 UTC

Omandamised, ülevõtmised, äriostud

13D Filings -- Barrons.com

13. märts 2026, 22:27 UTC

Market Talk
Uudisväärsed sündmused

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13. märts 2026, 22:13 UTC

Market Talk
Uudisväärsed sündmused

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13. märts 2026, 22:04 UTC

Market Talk
Uudisväärsed sündmused

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13. märts 2026, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13. märts 2026, 20:50 UTC

Market Talk
Uudisväärsed sündmused

Financial Services Roundup: Market Talk

13. märts 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13. märts 2026, 19:50 UTC

Market Talk
Uudisväärsed sündmused

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13. märts 2026, 19:35 UTC

Uudisväärsed sündmused

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Carlsberg A-S (Class B) Prognoos

Hinnasiht

By TipRanks

17.86% tõus

12 kuu keskmine prognoos

Keskmine 1,182.71 DKK  17.86%

Kõrge 1,300 DKK

Madal 925 DKK

Põhineb 7 Wall Streeti analüütiku instrumendi Carlsberg A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

7 ratings

5

Osta

0

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Carlsberg A-S (Class B)

Carlsberg A/S produces and sells beer and other beverage products in Denmark, China, the United Kingdom, and internationally. The company offers core, and craft and specialty beers; and alcohol-free brews. It provides its products under various brands. The company was founded in 1847 and is headquartered in Copenhagen, Denmark.
help-icon Live chat